LVGN6051
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LVGN6051, covering 2024-06-27 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]